XEU:CA:TSX-iShares MSCI Europe IMI (CAD)

ETF | European Equity |

Last Closing

CAD 31.38

Change

-0.27 (-0.85)%

Market Cap

CAD 0.32B

Volume

2.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for European Equity

Symbol Name Price(Change) Market Cap
ZEQ:CA BMO MSCI Europe High Quality C..

-0.22 (-0.69%)

CAD 1.10B
ZWP:CA BMO Europe High Dividend Cover..

-0.04 (-0.21%)

CAD 0.78B
ZWE:CA BMO Europe High Dividend Cover..

-0.06 (-0.29%)

CAD 0.61B
VE:CA Vanguard FTSE Developed Europe..

-0.27 (-0.72%)

CAD 0.20B
XEH:CA iShares MSCI Europe IMI CAD He..

-0.18 (-0.54%)

CAD 0.14B
RPD:CA RBC Quant European Dividend Le..

-0.25 (-0.93%)

CAD 0.03B
EDGF:CA Brompton European Dividend Gro..

-0.03 (-0.27%)

CAD 0.02B
RPDH:CA RBC Quant European Dividend Le..

-0.29 (-1.07%)

CAD 0.01B
EHE:CA CI Europe Hedged Equity Index ..

+1.30 (+4.15%)

CAD 1.58M
HXX:CA Global X Europe 50 Index Corpo..

-0.69 (-1.29%)

N/A

ETFs Containing XEU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (European Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.21% 68% D+ 52% F
Dividend Return 2.26% 31% F 52% F
Total Return 14.48% 68% D+ 55% F
Trailing 12 Months  
Capital Gain 22.87% 77% C+ 61% D-
Dividend Return 3.49% 56% F 58% F
Total Return 26.36% 77% C+ 64% D
Trailing 5 Years  
Capital Gain 38.73% 68% D+ 62% D
Dividend Return 12.90% 36% F 53% F
Total Return 51.63% 68% D+ 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.99% N/A N/A 61% D-
Dividend Return 9.28% N/A N/A 63% D
Total Return 2.29% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 14.80% N/A N/A 74% C
Risk Adjusted Return 62.71% N/A N/A 79% B-
Market Capitalization 0.32B 65% D 52% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.